Nova Leap Health Corp. Announces Oversubscribed Non-Brokered Private Placement of Convertible Debentures and Increase in Off...
20 Dezembro 2019 - 10:10AM
NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or the “Company”),
a 2019 TSX Venture 50™ ranked company focused on the home health
care industry, is pleased to announce an increase in size of its
previously announced non-brokered private placement of unsecured
subordinated convertible debentures (the “Debentures”). Due
to oversubscribed demand, the non-brokered private placement of
Debentures will now consist of maximum gross proceeds of CAD$3
million (the “Offering”).
The Offering is subject to certain conditions
including, but not limited to, the receipt of all necessary
regulatory and stock exchange approvals, including the approval of
the TSX Venture Exchange.
The securities being offered have not been, nor
will they be, registered under the United States Securities Act of
1933, as amended, and may not be offered or sold in the United
States or to, or for the account or benefit of, U.S. persons absent
registration or an applicable exemption from the registration
requirements. This press release shall not constitute an
offer to sell or the solicitation of an offer to buy nor shall
there be any sale of the securities in any State in which such
offer, solicitation or sale would be unlawful.
About Nova Leap
Nova Leap is an acquisitive home health care
services company operating in one of the fastest growing industries
in the U.S. & Canada. The Company performs a vital role
within the continuum of care with an individual and family centered
focus, particularly those requiring dementia care. Nova Leap
achieved the #10 Ranking in the 2019 TSX Venture 50™ in the Clean
Technology & Life Sciences sector. The Company is
geographically diversified with operations in 5 different U.S.
states: Vermont, New Hampshire, Massachusetts, Rhode Island and
Oklahoma as well as Nova Scotia, Canada.
FORWARD LOOKING
INFORMATION:
Certain information in this press release may
contain forward-looking statements, such as statements regarding
completion of the Offering and the use of the net proceeds of the
Offering. This information is based on current expectations and
assumptions, including assumptions concerning the Company’s ability
to satisfy the conditions to closing of the Offering, that are
subject to significant risks and uncertainties that are difficult
to predict. Actual results might differ materially from results
suggested in any forward-looking statements. Risks that could cause
results to differ from those stated in the forward-looking
statements in this release include regulatory changes affecting the
home care industry, unexpected increases in operating costs and
competition from other service providers. All forward-looking
statements, including any financial outlook or future-oriented
financial information, contained in this press release are made as
of the date of this release and included for the purpose of
providing information about management's current expectations and
plans relating to the future. The Company assumes no obligation to
update the forward-looking statements, or to update the reasons why
actual results could differ from those reflected in the forward
looking-statements unless and until required by securities laws
applicable to the Company. Additional information identifying risks
and uncertainties is contained in the Company's filings with the
Canadian securities regulators, which filings are available at
www.sedar.com.
CAUTIONARY STATEMENT:
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For further information:
Christopher Dobbin, CPA, CA, Director, President and CEO Nova Leap Health Corp., T: 902 401 9480 F: 902 482 5177 cdobbin@novaleaphealth.com
Nova Leap Health (TSXV:NLH)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Nova Leap Health (TSXV:NLH)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025